Detalhe da pesquisa
1.
The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
Hum Mol Genet
; 33(10): 919-929, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339995
2.
Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
Hemoglobin
; 45(3): 163-170, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355623
3.
Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database.
Blood Cells Mol Dis
; 84: 102438, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504882
4.
HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
Blood Cells Mol Dis
; 78: 22-28, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30773433
5.
Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN™) in Screening for Sickle Cell Disease.
Hemoglobin
; 41(2): 77-82, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28617057
6.
Corrigendum to "Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database" [Blood Cells, Molecules and Diseases (2020) Start page-End page/202438].
Blood Cells Mol Dis
; 88: 102480, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32739321
7.
Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders.
Front Genet
; 14: 1052444, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36816043
8.
Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria.
Front Genet
; 13: 1013858, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36386848
9.
Outcome of Hydroxyurea Use in SCD and Evaluation of Patients' Perception and Experience in Nigeria.
Front Genet
; 13: 826132, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35401653
10.
Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria.
PLoS One
; 17(11): e0276639, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355850
11.
Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica.
Front Genet
; 13: 1052179, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36712852
12.
Establishing a database for sickle cell disease patient mapping and survival tracking: The sickle pan-african research consortium Nigeria example.
Front Genet
; 13: 1041462, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36406113
13.
Comparative analysis of the nutritional, biochemical and hematological parameters of pregnant women attending the University of Abuja Teaching Hospital, Nigeria.
Biomedicine (Taipei)
; 12(1): 1-13, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35836914
14.
Barriers to Therapeutic Use of Hydroxyurea for Sickle Cell Disease in Nigeria: A Cross-Sectional Survey.
Front Genet
; 12: 765958, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35126450
15.
Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
Lancet Haematol
; 7(7): e534-e540, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589979
16.
A Multi-centre Survey of Acceptability of Newborn Screening for Sickle Cell Disease in Nigeria.
Cureus
; 10(3): e2354, 2018 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32181059